Publication: A rare cause of multiple small bowel ulcers and strictures in a 10-year-old child
Issued Date
2018-01-01
Resource Type
ISSN
21485607
13004948
13004948
Other identifier(s)
2-s2.0-85051165989
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Turkish Journal of Gastroenterology. Vol.29, No.1 (2018), 112-115
Suggested Citation
Teera Kijmassuwan, Pornthep Tanpowpong, Sani Molagool, Suporn Treepongkaruna A rare cause of multiple small bowel ulcers and strictures in a 10-year-old child. Turkish Journal of Gastroenterology. Vol.29, No.1 (2018), 112-115. doi:10.5152/tjg.2018.17232 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/47071
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A rare cause of multiple small bowel ulcers and strictures in a 10-year-old child
Other Contributor(s)
Abstract
© Copyright 2018 by The Turkish Society of Gastroenterology. Enteritis and small bowel ulcers can be caused by inflammatory bowel disease, drug-induced enteritis, cytomegalovirus, tuberculosis, or intestinal lymphoma. Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) is an uncommon idiopathic cause of ulceration and stricture of the small bowel. CMUSE can occur in adults, but only few pediatric cases have been reported. Inflammatory bowel disease and other causes should be carefully sought first before the diagnosis of CMUSE can be made. Previous reports demonstrated that surgical intervention may be necessary for both diagnostic and therapeutic purposes. With regard to the management, systemic corticosteroids may help, and surgery plays a role in patients present with signs of intestinal obstruction. We report a young girl who presented with a prolonged history of refractory iron deficiency anemia with protein-losing enteropathy without other obvious gastrointestinal symptoms. She underwent several laboratory and endoscopic investigations as well as histopathology of the resected full-thickness small bowel area before a proposed diagnosis of CMUSE was made. A trial of immunosuppression (both prednisolone and azathioprine) was initiated that provided a relatively satisfactory result.